Zusammenfassung
Symptomatische mesenteriale Durchblutungsstörungen sind ein potenziell lebensbedrohliches Krankheitsbild mit aufgrund der demographischen Bevölkerungsentwicklung zunehmender Häufigkeit. Nierenarterienstenosen sind Ursache einer arteriellen Hypertonie oder deren verschlechterter Einstellbarkeit sowie bei arteriosklerotischer Genese einer zum Teil progredienten Niereninsuffizienz. Weitere Folgen wie linksventrikuläre Myokardhypertrophie und hypertensive Enzephalopathie sind Gegenstand neuerer Forschung. Fortschritte in der Kathetertechnologie haben in den letzten 10 Jahren die Gefäßchirurgie als Methode der Wahl zur Revaskularisation der meist ostialen arteriosklerotischen Stenosen abgelöst. Die einzige randomisierte Studie (ASTRAL) konnte bisher den Nutzen der Stentrevaskularisation von Nierenarterienstenosen gegenüber der konservativen Therapie nicht belegen.
Abstract
Symptomatic mesenteric circulatory disorders are potentially life- threatening diseases with an increasing frequency due to the demographic population development. Renal artery stenosis is a well accepted cause of hypertension or at least deterioration of blood pressure control as well as the cause of a progressive course of renal insufficiency if of an atherosclerotic nature. Further consequences of renal artery stenosis, such as left ventricle hypertrophy and hypertensive encephalopathy are topics of recent research. Due to progress in percutaneous techniques during the last decade interventional therapy has replaced surgery as the treatment method of choice for lesions located near the origin. The only randomized study comparing endovascular stent revascularization with best medical therapy (ASTRAL) failed to show a benefit of revascularization of renal artery stenoses.
Literatur
American Gastroenterological Association (2000) American Gastroenterological Association Medical Position Statement: Guidelines on intestinal ischemia. Gastroenterology 118: 951–953
Balk E, Raman G, Chung M, Ip S et al. (2006) Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med 145: 901–912
Caps MT, Zierler RE, Polissar NL et al. (1998) Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 53: 735–742
Gallego AM, Ramirez P, Rodriguez JM et al. (1996) Role of urokinase in the superior mesenteric artery embolism. Surgery 120: 111–113
Hirsch AT, Haskal ZJ, Hertzer NR et al. (2006) ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). J Am Coll Cardiol 47: 1239–312
Krijnen P, van Jaarsveld BC, Deinum JS et al. (2004) Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention? J Hum Hypertens 18: 91–96
Luther B (2009) Akuter Intestinalarterienverschluss. In: Deutsche Gesellschaft für Gefäßchirurgie (Hrsg) Leitlinien der Gefäßchirurgie. 2. Aufl. Deutscher Ärzte-Verlag (im Druck)
Mitchell EL, Moneta GL (2006) Mesenteric duplex scanning. Perspect Vasc Surg Endovasc Ther 19: 175–183
Moawad J, Gewertz BL (1997) Chronic mesenteric ischemia. Clinical presentation and diagnosis. Surg Clin North Am 77: 357–369
Moneta GL, Yeager RA, Dalman et al. (1991) Duplex ultrasound criteria for diagnosis of splanchnic artery stenosis or occlusion. J Vac Surg 14: 511–515
Nordmann AJ, Woo K, Parkes R, Logan AG (2003) Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 114: 44–50
Radermacher J, Chavan A, Schäffer J et al. (2000) Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure. Clin Nephrol 53: 333–343
Radermacher J, Chavan A, Bleck J et al. (2001) Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 334: 410–417
Rundback JH, Sacks D, Kent KC et al. (2002) Guidelines for the reporting of renal artery revascularization in clinical trials. Circulation 106: 1572–1585
Safian RD, Textor SC (2001) Renal-artery stenosis. N Engl J Med 344: 431–442
Sheehan SR (2000) Acute mesenteric ischemia: recent advances in diagnosis and endovascular therapy. Emerg Radiol 7: 231–236
Shih MC, Hagspiel KD (2007) CTA and MRA in mesenteric ischemia: Part I Role in diagnosis and differential diagnosis. AJR Am J Roentgenol 188: 452–461
Silva JA, White CJ, Collins TJ et al. (2006) Endovascular Therapy for chronic mesenteric ischemia. J Am Coll Cardiol 47: 944–950
Silva JA, Chan AW, White CJ et al. (2005) Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 111: 328–333
Taylor LM, Porter JM (1995) Treatment of acute intestinal ischemia caused by arterial occlusions. In: Rutherford RB (ed) Vascular Surgery. 4th edn. WB Saunders, Philadelphia, pp 1278–1284
Van Jaarsveld BC, Krijnen P, Pieterman H, et al.; Dutch Renal Artery Stenosis Intervention Cooperative Study Group (2000) The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N Engl J Med 342: 1007–1014
Zeller T, Rastan A, Schwarzwälder U et al. (2007) Endovascular therapy of chronic mesenteric ischemia. Eurointervention 2: 444–451
Zeller T, Frank U, Müller C et al. (2004) Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: Long-term results of a prospective registry with 456 lesions. J Endovasc Ther 11: 95–106
Zeller T, Müller C, Frank U et al. (2003) Stent-angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. Catheter Cardiovasc Interv 58: 510–515
Zeller T, Rastan A, Schwarzwälder U et al. (2007) Regression of left ventricular hypertrophy following stenting of renal artery stenosis. J Endovasc Ther 14: 189–197
Zwolak RM, Fillinger MF, Walsh DB et al. (1998) Mesenteric and celiac duplex scanning: a validation study. J Vasc Surg 27: 1078–1087
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehungen hin:
Kooperation im Rahmen von Studien mit BARD, Pathway Medical, Invatec, Cook, Cordis, Abbott Vascular, ev3, Biotronic, Angioslide. Es besteht jedoch kein Zusammenhang zwischen Firmeninteressen und dem vorliegenden Artikel.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brunkhorst, R., Lorenzen, H. & Zeller, T. Durchblutungsstörungen der Nieren- und Mesenterialarterien. Internist 50, 952–957 (2009). https://doi.org/10.1007/s00108-009-2368-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-009-2368-0